Skip to main content

LimFlow Receives CE Mark for Purely Percutaneous Critical Limb Ischemia (CLI) Technology Designed to Restore Perfusion for “No Option” Patients

By November 15, 2016October 29th, 2024Healthcare

LimFlow Receives CE Mark for Purely Percutaneous Critical Limb Ischemia (CLI) Technology Designed to Restore Perfusion for “No Option” Patients

https://www.businesswire.com/news/home/20161115005740/en/LimFlow-Receives-CE-Mark-Purely-Percutaneous-Critical

Tags:

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality
Healthcare
Shipping
Alternatives
Media room
About
Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks